Achyut Healthcare Reports Strong FY26 Revenue Growth with Profit Squeeze

Revenue Jumps, Profit Falls in Fiscal Year 2026

Achyut Healthcare Limited announced its audited financial results for the fiscal year ending March 31, 2026 (FY26). The company reported a robust revenue from operations of ₹11.59 crore, a substantial 280% increase compared to ₹3.05 crore in the previous fiscal year (FY25). Despite this significant top-line growth, the company's net profit saw a 38% decline, dropping to ₹0.32 crore in FY26 from ₹0.51 crore in FY25. This reduction in profitability was primarily attributed to increased operational expenses, including higher costs for purchasing traded goods.

Expansion Drives Growth, Costs Pressure Margins

The impressive revenue growth highlights Achyut Healthcare's expanding business activities and its growing market presence. However, the drop in net profit alongside increased sales indicates pressure on the company's profit margins. This suggests that operating costs, particularly purchase expenses, are rising at a faster rate than revenue. Investors will be looking for clear strategies to manage these costs and improve profitability. The company's commitment to growth is further underscored by a significant increase in Capital Work in Progress (CWIP) to ₹27.88 crore as of March 31, 2026, up from ₹18.29 crore in FY25. This substantial investment signals ongoing expansion projects expected to fuel future growth.

Corporate Milestones and Financial History

Achyut Healthcare is currently in an expansionary phase, as demonstrated by its strong revenue performance. The company also recently completed its migration to the BSE Main Board, marking a positive corporate development. In the fiscal year 2025, Achyut Healthcare had reported revenues of ₹3.05 crore and a net profit of ₹0.51 crore. Earlier, on March 23, 2026, the company had issued 58,00,000 equity shares at ₹6 per share.

Future Outlook and Investor Focus

Looking ahead, investors will closely monitor Achyut Healthcare's efforts to enhance its profit margins through effective expense management in the upcoming quarters. The success of its ongoing expansion projects, reflected in the significant CWIP, will be critical in driving tangible revenue and profit growth. The company's financial statements received an unmodified auditor's opinion, providing assurance regarding the accuracy of the reported figures.

Key Risks and Monitoring Points

The main challenge for Achyut Healthcare lies in its ability to control rising operating costs, especially purchase costs, which are directly impacting its profitability. Additionally, the successful execution and return on investment for the expansion projects represented by the high CWIP will require careful oversight to ensure they meet expectations.

Performance Metrics

• Revenue from Operations (FY26): ₹11.59 crore (up 280% from FY25)
• Net Profit (FY26): ₹0.32 crore (down 38% from FY25)
• Capital Work in Progress (as of March 31, 2026): ₹27.88 crore (up from ₹18.29 crore in FY25)